These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16898478)

  • 21. Atypical hemolytic-uremic syndrome in a child presenting with malignant hypertension.
    Totina A; Iorember F; El-Dahr SS; Yosypiv IV
    Clin Pediatr (Phila); 2013 Feb; 52(2):183-6. PubMed ID: 21708810
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemolytic uraemic syndrome following acute pancreatitis.
    Sinha A; Rai R
    JOP; 2005 Jul; 6(4):365-8. PubMed ID: 16006689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic factors in the haemolytic uremic syndrome. Diagnostic and therapeutic implications].
    Rodríguez de Córdoba S; Peña A; Rivera F; López Trascasa M; Sánchez-Corral P
    Nefrologia; 2004; 24(1):9-11. PubMed ID: 15083952
    [No Abstract]   [Full Text] [Related]  

  • 24. Recurrence of hemolytic uremic syndrome after renal transplantation.
    Seitz B; Albano L; Vocila F; Mzoughi S; Aoudia R; Guitard J; Ribes D; Vachet-Copponat H; Mourad G; Bienaimé F; Dahan P; Frémeaux-Bacchi V; Cassuto E
    Transplant Proc; 2007 Oct; 39(8):2583-5. PubMed ID: 17954182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in understanding of pathogenesis of aHUS and HELLP.
    Fang CJ; Richards A; Liszewski MK; Kavanagh D; Atkinson JP
    Br J Haematol; 2008 Nov; 143(3):336-48. PubMed ID: 18691170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognosis of the hemolytic-uremic syndrome].
    Vermeer BJ; Troelstra JA; Elema JD
    Ned Tijdschr Geneeskd; 1972 Apr; 116(18):731-6. PubMed ID: 5019659
    [No Abstract]   [Full Text] [Related]  

  • 28. Kidney transplantation in atypical haemolytic uraemic syndrome (aHUS): a cheap way out?
    Bemelman FJ; ten Berge IJ
    Neth J Med; 2013 Sep; 71(7):339-41. PubMed ID: 24038558
    [No Abstract]   [Full Text] [Related]  

  • 29. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
    Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM
    Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome.
    Kwon T; Dragon-Durey MA; Macher MA; Baudouin V; Maisin A; Peuchmaur M; Fremeaux-Bacchi V; Loirat C
    Nephrol Dial Transplant; 2008 Jun; 23(6):2088-90. PubMed ID: 18326881
    [No Abstract]   [Full Text] [Related]  

  • 31. [Familial and recurrent hemolytic-uremic syndrome: apropos a case].
    Barriuso Lapresa LM; Nadal Lizabe I; del Moral Aldaz JM
    An Esp Pediatr; 1996 Feb; 44(2):167-9. PubMed ID: 8830580
    [No Abstract]   [Full Text] [Related]  

  • 32. Adult haemolytic-uraemic syndrome (HUS).
    Prakash J; Singh RG; Tripathi K; Usha ; Pandey LK; Tewari P; Srivastava PK
    J Assoc Physicians India; 1986 Nov; 34(11):815-7. PubMed ID: 3558312
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement hyperactivation may cause atypical haemolytic uraemic syndrome--gain-of-function mutations in factor B.
    Caprioli J; Remuzzi G
    Nephrol Dial Transplant; 2007 Sep; 22(9):2452-4. PubMed ID: 17510099
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemolytic uremic syndrome.
    Chan JC
    Int J Pediatr Nephrol; 1982 Sep; 3(3):219-24. PubMed ID: 7141794
    [No Abstract]   [Full Text] [Related]  

  • 36. Two clusters of haemolytic uraemic syndrome in France.
    Commun Dis Rep CDR Wkly; 1994 Feb; 4(7):29. PubMed ID: 7512404
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.
    Ståhl AL; Kristoffersson A; Olin AI; Olsson ML; Roodhooft AM; Proesmans W; Karpman D
    Mol Immunol; 2009 Jul; 46(11-12):2236-43. PubMed ID: 19446882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombomodulin in atypical hemolytic-uremic syndrome.
    Edey MM
    N Engl J Med; 2009 Oct; 361(15):1511; author reply 1511. PubMed ID: 19812413
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differing severity of D+ haemolytic uraemic syndrome in identical twins predicted from their neutrophil counts.
    Coulthard MG; Lambert HJ
    Pediatr Nephrol; 1994 Aug; 8(4):528-9. PubMed ID: 7947055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.